Tempus, a precision medicine company, raised $100 million in Series G financing round at a post-money valuation of $5 billion. Investors include: The investors include
![Early Stage Funding Deals Have Dominated Digital Health Since 2010](https://mercomcapital.com/wp-content/uploads/2020/03/Mercom-25.png)
Tempus, a precision medicine company, raised $100 million in Series G financing round at a post-money valuation of $5 billion. Investors include: The investors include
Concerto HealthAI, a provider of enterprise artificial intelligence and real-world data solutions for precision oncology, raised $150 million in aggregate Series B financing. Declaration Partners,